This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Fahl SP , Contreras AV , Verma A , Qiu X , Harly C , Radtke F , Zúñiga-Pflücker JC , Murre C , Xue HH , Sen JM , Wiest DL
The E protein-TCF1 axis controls γδ T cell development and effector fate
Cell Rep. 2021 Feb 2;34(5) :108716
PMID: 33535043 PMCID: PMC7919611 URL: https://www.ncbi.nlm.nih.gov/pubmed/33535043
AbstractTCF1 plays a critical role in T lineage commitment and the development of αβ lineage T cells, but its role in γδ T cell development remains poorly understood. Here, we reveal a regulatory axis where T cell receptor (TCR) signaling controls TCF1 expression through an E-protein-bound regulatory element in the Tcf7 locus, and this axis regulates both γδ T lineage commitment and effector fate. Indeed, the level of TCF1 expression plays an important role in setting the threshold for γδ T lineage commitment and modulates the ability of TCR signaling to influence effector fate adoption by γδ T lineage progenitors. This finding provides mechanistic insight into how TCR-mediated repression of E proteins promotes the development of γδ T cells and their adoption of the interleukin (IL)-17-producing effector fate. IL-17-producing γδ T cells have been implicated in cancer progression and in the pathogenesis of psoriasis and multiple sclerosis.
Notes2211-1247 Fahl, Shawn P Contreras, Alejandra V Verma, Anjali Qiu, Xiang Harly, Christelle Radtke, Freddy Zúñiga-Pflücker, Juan Carlos Murre, Cornelis Xue, Hai-Hui Sen, Jyoti Misra Wiest, David L Journal Article United States Cell Rep. 2021 Feb 2;34(5):108716. doi: 10.1016/j.celrep.2021.108716.